| Objective: To investigate the current situation of the medical institutions to implement the monitoring and control drug prices, understanding the awareness and attitudes of healthcare professionals towards Red-Yellow-Green monitoring and other pharmaceutical price regulation measures, for reference of standardizing and improving drug price monitoring and management. Methods: A questionnaire survey was conducted in the sample medical institutions, and semi-structured interviews were conducted with relevant personnel. On the basis of descriptive statistical analysis, inferential statistical analysis was conducted on the implementation differences of medical institutions at different levels. Results: A total of 370 valid questionnaires were collected from 25 medical institutions. 76.8% of the respondents believed that the current drug prices showed a stable to declining trend, and the perception of tertiary medical institutions was greater than that of secondary medical institutions (P=0.034) and lower than that of secondary medical institutions (P=0.005). Medical staff generally believed that the drug price regulation policy had a certain impact on their prescription behavior, mainly affecting the proportion of drug proportion (n=323, 87.3%), centralized bulk-buying (n=294, 79.5%) and basic drugs (n=294, 79.5%). Clinical effect (n=178, 48.1%) and drug price (n=147, 39.7%) were the priority factors for medical staff to prescribe.The interviews showed that the drug management personnel of medical institutions did not have a proper understanding of the Red-Yellow-Green Price Monitoring Policy, and some medical institutions had not established a complete and transparent internal management system. Conclusion: The drug price control policy is effective in medical institutions. However, the complexity of different drug regulatory policies has a certain limiting effect on doctors" prescribing behavior. It is suggested that different policies should be well coordinated and refined, medical institutions should establish a transparent price monitoring system, and strengthen the training of medical staff. |